[EFSA]意見等 -内分泌かく乱作用を持つ物質の特定に関連する有害性発現経路の開発 Development of Adverse Outcome Pathways relevant for the identification of substances having endocrine disruptors properties EFSA Journal 2023;20(2):EN-7748 14 Fe…